These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 35843942)

  • 1. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
    Lin H; Wang Y; Wang P; Long F; Wang T
    Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects.
    Tang X; Guo M; Zhang Y; Lv J; Gu C; Yang Y
    J Exp Clin Cancer Res; 2024 Aug; 43(1):216. PubMed ID: 39095902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
    Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
    Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.
    Li R; Zhu C; Wang Y; Wang X; Wang Y; Wang J; Wang K
    Cell Death Dis; 2024 Apr; 15(4):275. PubMed ID: 38632251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
    Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
    Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
    Qin S; Mao Y; Wang H; Duan Y; Zhao L
    Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel insights into the interplay between m
    Yi YC; Chen XY; Zhang J; Zhu JS
    Mol Cancer; 2020 Aug; 19(1):121. PubMed ID: 32767982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between circRNAs and m6A modifications in solid tumors.
    Liu F; Gu W; Shao Y
    J Transl Med; 2024 Jul; 22(1):694. PubMed ID: 39075555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel insights into the interaction between N6-methyladenosine modification and circular RNA.
    Xu T; He B; Sun H; Xiong M; Nie J; Wang S; Pan Y
    Mol Ther Nucleic Acids; 2022 Mar; 27():824-837. PubMed ID: 35141044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.
    Ge Y; Liu T; Wang C; Zhang Y; Xu S; Ren Y; Feng Y; Yin L; Pu Y; Liang G
    RNA Biol; 2021 Nov; 18(sup2):551-561. PubMed ID: 34674600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders.
    Han J; Kong H; Wang X; Zhang XA
    Cell Prolif; 2022 Oct; 55(10):e13294. PubMed ID: 35735243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between N6-methyladenosine modification and circular RNAs: current understanding and future directions.
    Wang X; Ma R; Zhang X; Cui L; Ding Y; Shi W; Guo C; Shi Y
    Mol Cancer; 2021 Sep; 20(1):121. PubMed ID: 34560891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the interaction between m6A modification and lncRNA in cancer drug resistance.
    Jin Y; Fan Z
    Cell Prolif; 2024 Apr; 57(4):e13578. PubMed ID: 37961996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology.
    Wu J; Guo X; Wen Y; Huang S; Yuan X; Tang L; Sun H
    Front Cell Dev Biol; 2021; 9():709299. PubMed ID: 34368159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.
    Qin S; Mao Y; Chen X; Xiao J; Qin Y; Zhao L
    Int J Biol Sci; 2021; 17(12):3059-3079. PubMed ID: 34421350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
    Zhang Y; Xu Y; Bao Y; Luo Y; Qiu G; He M; Lu J; Xu J; Chen B; Wang Y
    Epigenetics; 2023 Dec; 18(1):2260213. PubMed ID: 37766615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
    Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
    Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
    Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
    Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of
    Tang M; Lv Y
    Int J Biol Sci; 2021; 17(9):2262-2277. PubMed ID: 34239354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells.
    Dou Z; Ma XT; Piao MN; Wang JP; Li JL
    Transl Cancer Res; 2024 Jun; 13(6):3106-3125. PubMed ID: 38988908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.